Found: 86
Select item for more details and to access through your institution.
Fluorescent PCR-based gene dose analysis for detection of deletion mutations in carriers of haemophilia.
- Published in:
- Haemophilia, 2013, v. 19, n. 6, p. e377, doi. 10.1111/hae.12233
- By:
- Publication type:
- Article
Sorafenib, a dual Raf kinase/vascular endothelial growth factor receptor inhibitor has significant anti-myeloma activity and synergizes with common anti-myeloma drugs.
- Published in:
- Oncogene, 2010, v. 29, n. 8, p. 1190, doi. 10.1038/onc.2009.403
- By:
- Publication type:
- Article
Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00859-x
- By:
- Publication type:
- Article
Serum BCMA levels predict outcomes in MGUS and smoldering myeloma patients.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 6, p. 1, doi. 10.1038/s41408-021-00505-4
- By:
- Publication type:
- Article
Utility of serum free light chain measurements in multiple myeloma patients not achieving complete response to therapy.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Quantification of clonal circulating plasma cells in newly diagnosed multiple myeloma: implications for redefining high-risk myeloma.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 10, p. 2060, doi. 10.1038/leu.2014.98
- By:
- Publication type:
- Article
Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12 482 persons from the National Health and Nutritional Examination Survey.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 7, p. 1537, doi. 10.1038/leu.2014.34
- By:
- Publication type:
- Article
Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12,482 persons from the National Health and Nutritional Examination Survey.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Inhibitor of apoptosis proteins as therapeutic targets in multiple myeloma.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 7, p. 1519, doi. 10.1038/leu.2014.2
- By:
- Publication type:
- Article
Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 5, p. 1122, doi. 10.1038/leu.2013.313
- By:
- Publication type:
- Article
Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 4, p. 980, doi. 10.1038/leu.2014.11
- By:
- Publication type:
- Article
New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG).
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 3, p. 525, doi. 10.1038/leu.2013.350
- By:
- Publication type:
- Article
The current status of minimal residual disease assessment in myeloma.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 2, p. 239, doi. 10.1038/leu.2013.306
- By:
- Publication type:
- Article
Relationship between initial clinical presentation and the molecular cytogenetic classification of myeloma.
- Published in:
- Leukemia (08876924), 2014, v. 28, n. 2, p. 398, doi. 10.1038/leu.2013.258
- By:
- Publication type:
- Article
Long-term outcome with lenalidomide and dexamethasone therapy for newly diagnosed multiple myeloma.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 10, p. 2062, doi. 10.1038/leu.2013.143
- By:
- Publication type:
- Article
Impact of primary molecular cytogenetic abnormalities and risk of progression in smoldering multiple myeloma.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 8, p. 1738, doi. 10.1038/leu.2013.86
- By:
- Publication type:
- Article
Risk of acute leukemia and myelodysplastic syndromes in patients with monoclonal gammopathy of undetermined significance (MGUS): a population-based study of 17 315 patients.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Risk of acute leukemia and myelodysplastic syndromes in patients with monoclonal gammopathy of undetermined significance (MGUS): a population-based study of 17 315 patients.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 6, p. 1391, doi. 10.1038/leu.2013.34
- By:
- Publication type:
- Article
Treatment patterns and outcomes in elderly patients with multiple myeloma.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 4, p. 971, doi. 10.1038/leu.2012.259
- By:
- Publication type:
- Article
Will the real myeloma please stand up?
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 4, p. 760, doi. 10.1038/leu.2012.359
- By:
- Publication type:
- Article
Serum free light chain ratio as a biomarker for high-risk smoldering multiple myeloma.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 4, p. 941, doi. 10.1038/leu.2012.296
- By:
- Publication type:
- Article
High levels of peripheral blood circulating plasma cells as a specific risk factor for progression of smoldering multiple myeloma.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 3, p. 680, doi. 10.1038/leu.2012.237
- By:
- Publication type:
- Article
Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group collaborative project.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 3, p. 711, doi. 10.1038/leu.2012.282
- By:
- Publication type:
- Article
Single-nucleotide polymorphism rs1052501 associated with monoclonal gammopathy of undetermined significance and multiple myeloma.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 2, p. 515, doi. 10.1038/leu.2012.232
- By:
- Publication type:
- Article
A phase III randomized trial of thalidomide plus zoledronic acid versus zoledronic acid alone in patients with asymptomatic multiple myeloma.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 1, p. 220, doi. 10.1038/leu.2012.236
- By:
- Publication type:
- Article
Suppression of uninvolved immunoglobulins defined by heavy/light chain pair suppression is a risk factor for progression of MGUS.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 1, p. 208, doi. 10.1038/leu.2012.189
- By:
- Publication type:
- Article
A window into immunoglobulin quantitation and plasma cell disease: antigen epitopes defined by the junction of immunoglobulin heavy and light chains.
- Published in:
- Leukemia (08876924), 2013, v. 27, n. 1, p. 1, doi. 10.1038/leu.2012.201
- By:
- Publication type:
- Article
Majority of patients receiving initial therapy with lenalidomide-based regimens can be successfully mobilized with appropriate mobilization strategies.
- Published in:
- Leukemia (08876924), 2012, v. 26, n. 5, p. 1119, doi. 10.1038/leu.2011.308
- By:
- Publication type:
- Article
Management of treatment-emergent peripheral neuropathy in multiple myeloma.
- Published in:
- Leukemia (08876924), 2012, v. 26, n. 4, p. 595, doi. 10.1038/leu.2011.346
- By:
- Publication type:
- Article
Disparities in the prevalence, pathogenesis and progression of monoclonal gammopathy of undetermined significance and multiple myeloma between blacks and whites.
- Published in:
- Leukemia (08876924), 2012, v. 26, n. 4, p. 609, doi. 10.1038/leu.2011.368
- By:
- Publication type:
- Article
Polymorphism of the erythropoietin gene promotor and the development of myelodysplastic syndromes subsequent to multiple myeloma.
- Published in:
- Leukemia (08876924), 2012, v. 26, n. 4, p. 844, doi. 10.1038/leu.2011.262
- By:
- Publication type:
- Article
Response to salvage therapies and outcome in patients with multiple myeloma relapsing after pomalidomide therapy.
- Published in:
- Leukemia (08876924), 2012, v. 26, n. 4, p. 839, doi. 10.1038/leu.2011.279
- By:
- Publication type:
- Article
MRK003, a γ-secretase inhibitor exhibits promising in vitro pre-clinical activity in multiple myeloma and non-Hodgkin's lymphoma.
- Published in:
- Leukemia (08876924), 2012, v. 26, n. 2, p. 340, doi. 10.1038/leu.2011.192
- By:
- Publication type:
- Article
Melphalan and prednisone versus melphalan, prednisone and thalidomide for elderly and/or transplant-ineligible patients with multiple myeloma: a meta-analysis.
- Published in:
- 2011
- By:
- Publication type:
- Correction notice
Efficacy of thalidomide- or lenalidomide-based therapy in proliferative multiple myeloma.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Incidence of extramedullary disease in patients with multiple myeloma in the era of novel therapy, and the activity of pomalidomide on extramedullary myeloma.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Melphalan and prednisone versus melphalan, prednisone and thalidomide for elderly and/or transplant ineligible patients with multiple myeloma: a meta-analysis.
- Published in:
- Leukemia (08876924), 2011, v. 25, n. 4, p. 689, doi. 10.1038/leu.2010.313
- By:
- Publication type:
- Article
Pomalidomide (CC4047) plus low dose dexamethasone (Pom/dex) is active and well tolerated in lenalidomide refractory multiple myeloma (MM).
- Published in:
- 2010
- By:
- Publication type:
- journal article
Relationship between elevated immunoglobulin free light chain and the presence of IgH translocations in multiple myeloma.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Bortezomib, dexamethasone, cyclophosphamide and lenalidomide combination for newly diagnosed multiple myeloma: phase 1 results from the multicenter EVOLUTION study.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Clinical value of minor responses after 4 doses of rituximab in Waldenström macroglobulinaemia: a follow-up of the Eastern Cooperative Oncology Group E3A98 trial.
- Published in:
- British Journal of Haematology, 2009, v. 147, n. 5, p. 677, doi. 10.1111/j.1365-2141.2009.07892.x
- By:
- Publication type:
- Article
Secondary MGUS after autologous hematopoietic progenitor cell transplantation in plasma cell myeloma: a matter of undetermined significance.
- Published in:
- Bone Marrow Transplantation, 2012, v. 47, n. 9, p. 1212, doi. 10.1038/bmt.2011.244
- By:
- Publication type:
- Article
Impact of early relapse after auto-SCT for multiple myeloma.
- Published in:
- Bone Marrow Transplantation, 2008, v. 42, n. 6, p. 413, doi. 10.1038/bmt.2008.180
- By:
- Publication type:
- Article
Impact of additional cytoreduction following autologous SCT in multiple myeloma.
- Published in:
- Bone Marrow Transplantation, 2008, v. 42, n. 4, p. 259, doi. 10.1038/bmt.2008.166
- By:
- Publication type:
- Article
Impact of pretransplant therapy in patients with newly diagnosed myeloma undergoing autologous SCT.
- Published in:
- Bone Marrow Transplantation, 2008, v. 41, n. 12, p. 1013, doi. 10.1038/bmt.2008.24
- By:
- Publication type:
- Article
Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains.
- Published in:
- Kidney International, 2008, v. 73, n. 11, p. 1282, doi. 10.1038/ki.2008.108
- By:
- Publication type:
- Article
International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma.
- Published in:
- Leukemia (08876924), 2009, v. 23, n. 9, p. 1545, doi. 10.1038/leu.2009.89
- By:
- Publication type:
- Article
Dexamethasone and the risk for adrenal suppression in multiple myeloma.
- Published in:
- 2009
- By:
- Publication type:
- letter
Treatment of newly diagnosed myeloma.
- Published in:
- 2009
- By:
- Publication type:
- journal article